close

Enter

Log in using OpenID

Testosterone Replacement Therapy Market New Opportunities For Growth Till 2026

embed
Increasing prevalence of hypogonadism in adult men worldwide is expected to drive growth of the testosterone replacement therapy market.
Testosterone Replacement Therapy Market
Size, Share, Trend, Outlook, Future Analysis
And Synthesis By 2026
Testosterone Replacement Therapy (TRT) or low testosterone therapy is commonly called hormone
therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism.
Hypogonadism in men is clinical syndrome, which results in the failure of the testes to produce
physiological levels of testosterone. Hypogonadism may be primary, due to a problem with the testes or
secondary due to a problem with the hypothalamus or pituitary gland or combined: primary and
secondary. Primary hypogonadism is caused due to genetic abnormalities, testicular trauma, orchitis,
radiation treatment or chemotherapy, while secondary hypogonadism is caused due to genetic
abnormalities of pituitary and hypothalamus.
Ask for In-depth Sample Copy of This Research @
https://www.coherentmarketinsights.com/insight/request-sample/2024
Testosterone Replacement Therapy Market – Drivers
Hypogonadism in men is primarily characterized by reduced concentration of serum testosterone, causing
decreased libido, erectile dysfunction, loss of body and facial hair, decreased bone density, weakness,
decreased lean body mass, increased body fat, fatigue and anemia. Hypogonadism in adult men is often
overlooked; even in the presence of associated symptoms, because the hypogonadism men often ignore
the symptoms or they attribute them with alternate cause such as ageing.
Increasing prevalence of hypogonadism in adult men worldwide is expected to drive growth of the
testosterone replacement therapy market. According to the European Association of Urology: 2016 report,
in middle-aged men, the incidence of hypogonadism varies from 2.1% to 12.8%. The incidence of low
testosterone and symptoms of hypogonadism in men aged 40-79 varies form 2.1% to 5.7%, in Europe.
Hypogonadism is more prevalent in older men, in men with obesity, those with co-morbidities, and in
men with a poor health status. Furthermore, according to the Therapeutics Advances of Urology Journal:
2016, testosterone has become one of the most widely prescribed medications in the U.S. in 2011. These
increase resulted in significant growth of testosterone replacement therapy, from US$ 18 million in the
1980 to US$ 1.6 billion in 2011, resulting in five-fold increase.
Testosterone Replacement Therapy Market – Regional Analysis
Geographically, global testosterone replacement therapy market is segmented into North
America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds
major share in the testosterone replacement therapy market, owing to increasing number of
people suffering from hypogonadism, combined with rising adoption of testosterone products in
the U.S. market. According to the data published in European Association of Urology Journal:
2017, testosterone prescription trends in the U.S. demonstrated an increase between 1.8-and 4fold over the last two decades (1997 - 2017). Moreover, from 2000 to 2011, there was a 4.3fold increase in testosterone testing compared to a 3.7-fold increase in prescriptions.
Report includes chapters which deeply display the following deliverable about industry :
• Testosterone Replacement Therapy Market Research Objective and Assumption
• Testosterone Replacement Therapy Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Testosterone Replacement Therapy Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Testosterone Replacement Therapy Market, By Regions
• Testosterone Replacement Therapy Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Testosterone Replacement Therapy Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Testosterone Replacement Therapy Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Testosterone Replacement Therapy Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Testosterone Replacement Therapy Market – Competitor
Some of the key players operating in the testosterone replacement therapy market include AbbVie, Inc.,
Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer,
Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.
Testosterone Replacement Therapy Market – Taxonomy
By Active Ingredient Type:
•
Testosterone
•
Methyl Testosterone
•
Testosterone Undecanoate
•
Testosterone Enanthate
•
Testosterone Cypionate
By Route of Administration:
•
Injectables
•
Parenteral
By Region:
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East
•
Africa
For More Information, Browse Here:
https://www.coherentmarketinsights.com/ongoing-insight/testosterone-replacement-therapy-market-2024
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called
PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials
for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps
biotechnology and pharmaceutical companies to analyze the market trend, competition, and market
potential. For more information or to access this database, kindly click on the below link or contact at
[email protected]
https://www.coherentmarketinsights.com/phase-xs/
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Poul Master
Poul Master247   documents Email
Document
Category
Health and Medicine
Views
26
File Size
121 KB
Tags
replacement, Testosterone Replacement Therapy Market
1/--pages
Report inappropriate content